REGENERON PHARMACEUTICALS, INC. — Director's Dealing 2021

Aug 4, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: REGENERON PHARMACEUTICALS, INC. (REGN)
CIK: 0000872589
Period of Report: 2021-08-02

Reporting Person: RYAN ARTHUR F (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-08-02	Common Stock	S	2	$572.94	Disposed	23489	Direct
2021-08-02	Common Stock	S	2	$573.2	Disposed	23487	Direct
2021-08-02	Common Stock	S	13	$574.7	Disposed	23474	Direct
2021-08-02	Common Stock	S	5	$575.24	Disposed	23469	Direct
2021-08-02	Common Stock	S	3	$576.51	Disposed	23466	Direct
2021-08-02	Common Stock	S	5	$577.42	Disposed	23461	Direct
2021-08-02	Common Stock	S	28	$578.67	Disposed	23433	Direct
2021-08-02	Common Stock	S	39	$579.35	Disposed	23394	Direct
2021-08-02	Common Stock	S	3	$580.33	Disposed	23391	Direct

Footnotes

F1: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F2: Represents volume-weighted average price of sales of 2 shares of Company stock on August 2, 2021 at prices ranging from $572.91 to $572.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 2, 2021 at each separate price.

F3: Represents volume-weighted average price of sales of 2 shares of Company stock on August 2, 2021 at prices ranging from $573.01 to $573.40. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 2, 2021 at each separate price.

F4: Represents volume-weighted average price of sales of 13 shares of Company stock on August 2, 2021 at prices ranging from $574.33 to $574.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 2, 2021 at each separate price.

F5: Represents volume-weighted average price of sales of 5 shares of Company stock on August 2, 2021 at prices ranging from $575.01 to $575.47. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 2, 2021 at each separate price.

F6: Represents volume-weighted average price of sales of 3 shares of Company stock on August 2, 2021 at prices ranging from $576.05 to $576.79. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 2, 2021 at each separate price.

F7: Represents volume-weighted average price of sales of 5 shares of Company stock on August 2, 2021 at prices ranging from $577.12 to $577.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 2, 2021 at each separate price.

F8: Represents volume-weighted average price of sales of 28 shares of Company stock on August 2, 2021 at prices ranging from $578.08 to $578.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 2, 2021 at each separate price.

F9: Represents volume-weighted average price of sales of 39 shares of Company stock on August 2, 2021 at prices ranging from $579.00 to $579.82. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 2, 2021 at each separate price.

F10: Represents volume-weighted average price of sales of 3 shares of Company stock on August 2, 2021 at prices ranging from $580.02 to $580.85. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 2, 2021 at each separate price.